Report Categories
View AllRecent Articles
View All
BPs LNG Strategy A Potential Contender for 2026 Growth
Australian Taxpayer Subsidies and BHP Climate Retreat Raise Questions on Emission Goals
Novartis Raises FullYear Sales and Profit Outlook
Info Edge Shares Dip 4 Despite Strong 22 Rise in Q4 Net Profit and 16 Revenue Growth
Core Inflation Hits 32 in March as FirstQuarter GDP Growth Slows to 2 Iran Conflict Drives Oil Prices Higher
Hagerty Inc HGTY Q1 2026 Earnings EPS Beat Surprises but Stock Declines on Profitability Concerns
LEGN Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Advances on Operational Progress
PLMR Q1 2026 Earnings Earnings Beat Driven by Underwriting Strength
MCD Q1 2026 Earnings EPS Slightly Above Estimates Amid Modest Stock Decline
MDWD Q4 2025 Earnings Narrower Loss Beats Estimates as Operational Focus Continues
NewAmsterdam Pharma NAMS Edges Higher as Shares Test Key Resistance Level
JFB Construction Holdings JFB Slides 226 as Selling Pressure Tests 519 Level
Akari Therapeutics AKTX Dips 25 Holding Above Critical Support Level
Thornburg Income Builder Opportunities Trust TBLD Holds Steady Above Key Support Eyes Resistance
Longevity Biotech Stocks Rally as 27 Trillion Healthcare Shift Embraces Cell Restoration Therapies
Gaza Flotilla Allegations Could Heighten Geopolitical Uncertainty
Wingstop Shares Slide 12 After Earnings Miss Profit Estimates
US Stock Futures and Bond Yields Fall as Putin Updates Nuclear Doctrine
External Links
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed
Rekor Systems REKR Faces Continued Pressure Near Key Support Level
LCI Industries LCII Rises 228 as RV Demand Recovery Gains Traction
South Plains Financial Inc SPFI Edges Lower Analyzing Key Support and Resistance Levels
Bragg Gaming Group BRAG Navigates Near Support as Bearish Pressure Persists
Xunlei XNET Edges Lower Amid Consolidation Near 544
AgomAb Therapeutics AGMB Gains 366 as Buyers Defend Key Support Level
Grupo Cibest CIB Slides 13 ADR Tests Key Support as Sector Headwinds Persist
4D Molecular Therapeutics FDMT Gains 16 as Stock Holds Above Support